Abstract
The Covid-19 pandemic has become a major challenge for health care professionals and researchers all over the world. The discovery and development of new drugs require time for passing the quality, safety, and efficacy criteria. Hence the only available option is to rely on herbal or natural remedies as well as other existing ones. Nature has its healing power and has the remedy for all the ailments from which life on earth is struggling. For this pandemic situation also, nature should have created a remedy but finding a loophole is in the hands of our researchers. In this hypothesis, a novel combination strategy is introduced with the existing drugs such as hydroxychloroquine and flavonoid in a volatile liquid-based Nanoformulation incorporated into an inhaler as a possible remedy for the management of coronavirus infection. The synergistic activity of this combination shall pave the way for an effective therapeutic strategy for the treatment of COVID-19 symptoms.
Keywords: COVID-19, traditional treatment methods, flavonoids, nanoformulation, folatile solvents.
Graphical Abstract
Infectious Disorders - Drug Targets
Title:“Can Nature Heal and be a Possible Remedy for the Management of Covid-19?”
Volume: 21 Issue: 7
Author(s): Chenmala Karthika and Raman Sureshkumar*
Affiliation:
- Department of Pharmaceutics, JSS College of Pharmacy, JSS Academy of Higher Education & Research, P.B.20, Rocklands, Ooty-643001, Tamil Nadu,India
Keywords: COVID-19, traditional treatment methods, flavonoids, nanoformulation, folatile solvents.
Abstract: The Covid-19 pandemic has become a major challenge for health care professionals and researchers all over the world. The discovery and development of new drugs require time for passing the quality, safety, and efficacy criteria. Hence the only available option is to rely on herbal or natural remedies as well as other existing ones. Nature has its healing power and has the remedy for all the ailments from which life on earth is struggling. For this pandemic situation also, nature should have created a remedy but finding a loophole is in the hands of our researchers. In this hypothesis, a novel combination strategy is introduced with the existing drugs such as hydroxychloroquine and flavonoid in a volatile liquid-based Nanoformulation incorporated into an inhaler as a possible remedy for the management of coronavirus infection. The synergistic activity of this combination shall pave the way for an effective therapeutic strategy for the treatment of COVID-19 symptoms.
Export Options
About this article
Cite this article as:
Karthika Chenmala and Sureshkumar Raman *, “Can Nature Heal and be a Possible Remedy for the Management of Covid-19?”, Infectious Disorders - Drug Targets 2021; 21 (7) : e300821190175 . https://dx.doi.org/10.2174/1871526521999210111202954
DOI https://dx.doi.org/10.2174/1871526521999210111202954 |
Print ISSN 1871-5265 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-3989 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Goal Directed Fluid Therapy
Current Pharmaceutical Design Leptin in Thrombosis and Atherosclerosis
Current Pharmaceutical Design Pharmacologic Modulators of Soluble Guanylate Cyclase/Cyclic Guanosine Monophosphate in the Vascular System - From Bench Top to Bedside
Current Vascular Pharmacology Vasoactive Compounds in the Neonatal Period
Current Medicinal Chemistry Metal Complexes, their Cellular Targets and Potential for Cancer Therapy
Current Pharmaceutical Design Expression, Distribution and Regulation of Phosphodiesterase 5
Current Pharmaceutical Design Asymmetric Dimethylarginine: a Key Player in the Pathophysiology of Endothelial Dysfunction, Vascular Inflammation and Atherosclerosis in Rheumatoid Arthritis?
Current Pharmaceutical Design Potential Applications of FDG-PET/CT in COPD: A Review of the Literature
Current Molecular Imaging (Discontinued) Clinical Pharmacology and Role of Edoxaban in Contemporary Antithrombotic Therapy
Cardiovascular & Hematological Agents in Medicinal Chemistry Role of Nitric Oxide and Reactive Oxygen Species in Arthritis
Current Pharmaceutical Design Porphyromonas gingivalis Mediated Periodontal Disease and Atherosclerosis:Disparate Diseases with Commonalities in Pathogenesis Through TLRs
Current Pharmaceutical Design Methods to Measure Target Site Penetration of Antibiotics in Critically Ill Patients
Current Clinical Pharmacology New Advances in the Field of Calcium Channel Antagonists: Cardiovascular Effects and Structure-Activity Relationships
Current Medicinal Chemistry - Cardiovascular & Hematological Agents FDG-PET Scan in Sarcoidosis: Clinical and Imaging Indications
Current Medical Imaging Mepolizumab and Eosinophil-Mediated Disease
Current Medicinal Chemistry Beta-Blockers: Current State of Knowledge and Perspectives
Mini-Reviews in Medicinal Chemistry Pharmacy and Exercise as Complimentary Partners for Successful Cardiovascular Ageing
Current Vascular Pharmacology Novel and Emerging Drugs for Rarer Chronic Lymphoid Leukaemias
Current Cancer Drug Targets Safety of Inhaled Corticosteroids. Why the Variation in Systemic Adverse Effects?
Current Pediatric Reviews OX40:OX40L Axis: Emerging Targets for Immunotherapy of Human Disease
Current Immunology Reviews (Discontinued)